Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Micrornas As Potential Diagnostic and Prognostic Biomarkers in Melanoma Publisher Pubmed



Mirzaei H1 ; Gholamin S8 ; Shahidsales S2 ; Sahebkar A3 ; Jafaari MR4 ; Mirzaei HR5 ; Hassanian SM7, 9, 10 ; Avan A6, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  2. 2. Cancer Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  3. 3. Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  4. 4. Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
  5. 5. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Molecular Medicine Group, Department of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  7. 7. Biochemistry of Nutrition Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  8. 8. Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, United States
  9. 9. Department of Medical Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  10. 10. Microanatomy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Source: European Journal of Cancer Published:2016


Abstract

Melanoma is a life-threatening malignancy with poor prognosis and a relatively high burden of mortality in advanced stages. The efficacy of current available therapeutic strategies is limited, with a survival rate of less than 10%. Despite rapid advances in biomarker-guided drug development in different tumour types, including melanoma, only a very small number of biomarkers have been identified. Recently, microRNAs (miRNAs) have emerged as a molecular regulator in the development and progression of melanoma. Aberrant activation of some known miRNAs, e.g. let-7a and b, miR-148, miR-155, miR-182, miR-200c, miR-211, miR-214, miR-221 and 222, has been recognised to be linked with melanoma-associated genes such as NRAS, microphthalmia-associated transcription factor, receptor tyrosine kinase c-KIT, AP-2 transcription factor, etc. There is accumulating evidence suggesting the potential impact of circulating miRNAs as diagnostic and therapeutic markers in diseases. In addition, miRNAs have turned out to play important roles in drug-resistance mechanisms; suggesting their modulation as a potential approach to overcome chemoresistance. This review highlights recent preclinical and clinical studies on circulating miRNAs and their potential role as diagnosis, and therapeutic targets in melanoma. © 2015 Elsevier Ltd. All rights reserved.
Related Docs
View other Related Docs
1. Critical Considerations for Investigating Micrornas During Tumorigenesis: A Case Study in Conceptual and Contextual Nuances of Mir-211-5P in Melanoma, Epigenomes (2023)
2. The Role of Exosomes Contents on Genetic and Epigenetic Alterations of Recipient Cancer Cells, Iranian Journal of Basic Medical Sciences (2016)
3. Down-Regulation of Mir-200C and Up-Regulation of Mir-30C Target Both Stemness and Metastasis Genes in Breast Cancer, Cell Journal (2020)
4. Microfluidics for Detection of Exosomes and Micrornas in Cancer: State of the Art, Molecular Therapy Nucleic Acids (2022)
5. Liquid Biopsy in Thyroid Cancer: New Insight, International Journal of Hematology-Oncology and Stem Cell Research (2018)
6. Up-Regulation of Kiss1 As a Novel Target of Let-7I in Melanoma Serves As a Potential Suppressor of Migration and Proliferation in Vitro, Journal of Cellular and Molecular Medicine (2021)
7. Diagnostic Power of Micrornas in Melanoma: Integrating Machine Learning for Enhanced Accuracy and Pathway Analysis, Journal of Cellular and Molecular Medicine (2025)
8. The Extracellular Vesicles-Derived From Mesenchymal Stromal Cells: A New Therapeutic Option in Regenerative Medicine, Journal of Cellular Biochemistry (2018)
Experts (# of related papers)
View all Related Experts
Hamid Reza Mirzaei (5)
Bagher Larijani (4)
Other Related Docs
9. Micrornas Contribution in Tumor Microenvironment of Esophageal Cancer, Cancer Biomarkers (2016)
10. How Micrornas Affect the Pd-L1 and Its Synthetic Pathway in Cancer, International Immunopharmacology (2020)
11. Communication Between Stromal and Hematopoietic Stem Cell by Exosomes in Normal and Malignant Bone Marrow Niche, Biomedicine and Pharmacotherapy (2020)
12. Cellular Dust As a Novel Hope for Regenerative Cancer Medicine, Advances in Experimental Medicine and Biology (2020)
13. Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale?, Journal of Cellular Physiology (2017)
14. Micrornas-Based Imaging Techniques in Cancer Diagnosis and Therapy, Journal of Cellular Biochemistry (2017)
15. The Potential of Circulating Mir-193B, Mir-146B-3P and Mir-483-3P As Noninvasive Biomarkers in Cutaneous Melanoma Patients, Molecular Biotechnology (2023)
16. Microrna-181 Serves As a Dual-Role Regulator in the Development of Human Cancers, Free Radical Biology and Medicine (2020)
17. Microrna-184 in the Landscape of Human Malignancies: A Review to Roles and Clinical Significance, Cell Death Discovery (2023)
18. The Silencing Effect of Mir-30A on Itga4 Gene Expression in Vitro: An Approach for Gene Therapy, Research in Pharmaceutical Sciences (2017)
19. Regulation of Tumor Angiogenesis by Micrornas: State of the Art, Journal of Cellular Physiology (2019)
20. Reciprocal Interconnection of Mirnome-Epigenome in Cancer Pathogenesis and Its Therapeutic Potential, Epigenetics Territory and Cancer (2015)
21. Evaluating the Mir-302B and Mir-145 Expression in Formalin-Fixed Paraffin-Embedded Samples of Esophageal Squamous Cell Carcinoma, Archives of Iranian Medicine (2015)
22. Stat3 Targeting by Polyphenols: Novel Therapeutic Strategy for Melanoma, BioFactors (2017)
23. Immunology of Cutaneous Tumors and Immunotherapy for Melanoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
24. Recent Advances on High-Efficiency of Micrornas in Different Types of Lung Cancer: A Comprehensive Review, Cancer Cell International (2023)
25. Reproducible and Reliable Real-Time Pcr Assay to Measure Mature Form of Mir-141, Applied Immunohistochemistry and Molecular Morphology (2016)
26. Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications, Current Medicinal Chemistry (2021)
27. Novel Insights Into the Interaction Between Long Non-Coding Rnas and Micrornas in Glioma, Molecular and Cellular Biochemistry (2021)
28. Exosomal Mirnas: Novel Players in Viral Infection, Epigenomics (2020)
29. Modifying Exosome Release in Cancer Therapy: How Can It Help?, Pharmacological Research (2018)
30. Mesenchymal Stem/Stromal Cell-Derived Exosomes in Regenerative Medicine and Cancer; Overview of Development, Challenges, and Opportunities, Stem Cell Research and Therapy (2021)
31. Cancer Genetics at a Glance: The Comprehensive Insights, Cancer Genetics and Psychotherapy (2017)
32. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
33. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
34. Tumor-Derived Exosomal Micrornas and Proteins As Modulators of Macrophage Function, Journal of Cellular Physiology (2019)
35. Differential Role of Micrornas in Prognosis, Diagnosis, and Therapy of Ovarian Cancer, Biomedicine and Pharmacotherapy (2016)
36. Potential Role of Thymoquinone to Treat Gastrointestinal Cancers: Insights Into Its Molecular Mechanisms, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)
37. Oncometabolites As Biomarkers in Thyroid Cancer: A Systematic Review, Cancer Management and Research (2019)
38. Role of Non-Coding Rnas in Neuroblastoma, Cancer Gene Therapy (2023)
39. Exosomal Micrornas in Regulation of Tumor Cells Resistance to Apoptosis, Biochemistry and Biophysics Reports (2024)
40. Role of Micrornas in Chronic Lymphocytic Leukemia Pathogenesis, Current Medicinal Chemistry (2020)
41. Microbiota Alterations and Their Association With Oncogenomic Changes in Pancreatic Cancer Patients, International Journal of Molecular Sciences (2021)
42. Inflammation Related Mirnas As an Important Player Between Obesity and Cancers, Journal of Diabetes and Metabolic Disorders (2019)
43. Commercial and Regulatory Challenges in Cancer Nanomedicine, Functionalized Nanomaterials for Cancer Research: Applications in Treatments# Tools and Devices (2024)
44. Lung Cancer-Associated Brain Metastasis: Molecular Mechanisms and Therapeutic Options, Cellular Oncology (2017)
45. The Role of Oncomirs in the Pathogenesis and Treatment of Breast Cancer, Biomedicine and Pharmacotherapy (2016)
46. Monitoring of Microrna Using Molecular Beacons Approaches: Recent Advances, TrAC - Trends in Analytical Chemistry (2020)
47. Peptidomimetics in Cancer Targeting, Molecular Medicine (2022)
48. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
49. The Microrna Let-7 and Its Exosomal Form: Epigenetic Regulators of Gynecological Cancers, Cell Biology and Toxicology (2024)
50. Molecular Mechanisms of Curcumins Suppressing Effects on Tumorigenesis, Angiogenesis and Metastasis, Focusing on Nf-Κb Pathway, Cytokine and Growth Factor Reviews (2016)